Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
HbA1c-independent benefits of semaglutide on liver histology and non-invasive tests in participants with biopsy-defined MASH: insights from post hoc analysis of the ESSENCE trial part 1
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.